Disease Areas Aug 17, 2022 Sanofi Ends Development of Breast Cancer Drug Amcenestrant Aug 16, 2022 Invivoscribe, Kronos Bio Partner on Companion Diagnostic Test for Leukemia Drug Aug 16, 2022 Gilead Sciences Files for Trodelvy FDA Approval in HR-Positive Breast Cancer, Buys Rights in Asia Aug 15, 2022 Anixa Biosciences Doses First Ovarian Cancer Patient in Novel Autologous Cell Therapy Trial Aug 12, 2022 AstraZeneca, Daiichi Sankyo's Enhertu Scores FDA Accelerated Approval in HER2-Mutant Lung Cancer Aug 11, 2022 Novartis' Tabrecta Nets Full FDA Approval for NSCLC With METex14 Skipping Mutations Aug 11, 2022 New Drugs Going After 'Achilles' Heel' Resistance Mutation in NSCLC Premium Aug 11, 2022 Roche Nabs FDA Label Expansion for Ventana CDx Panel Aug 10, 2022 Bristol Myers Squibb, 2seventy Bio Eyeing Earlier-Line Multiple Myeloma Abecma Indication Aug 10, 2022 VolitionRx, MD Anderson Cancer Center Partner to Study Cancer Patients With Sepsis Aug 10, 2022 Mount Sinai Using $500K Grant to Study KRAS-Mutant Lung Cancer Treatments Aug 9, 2022 Amgen Finetuning Combination Strategy for Lumakras in NSCLC Following Safety Readouts Premium Aug 9, 2022 GSK, Mersana Therapeutics Ink $100M Option Agreement for Antibody-Drug Conjugate Aug 8, 2022 CAP Weighs in on dMMR, MSI Assays for Immunotherapy Patient Selection Premium Aug 8, 2022 Immuno-Genomic Features Predict Treatment Response in Esophageal Carcinoma Aug 8, 2022 Small Cell Lung Cancer Detection, Classification Achieved Using Cell-Free DNA Methylation Aug 8, 2022 Clovis Oncology Exploring Ways to Improve Cash Position, Fund Operations Beyond 2023 Premium Aug 8, 2022 Alercell to Distribute Amoy Diagnostic Ros1 Gene Fusion Detection Kit in US Aug 5, 2022 Polygenic Risk Score Firm Antegenes Aims to Invest in International Expansion, R&D Premium Aug 5, 2022 Chronic Lymphocytic Leukemia Genomic Study Reveals New Subtypes, Ties to Outcomes Load More Breaking News Verismo Therapeutics Files IND to Study Cell Therapy in Advanced Mesothelin-Expressing Solid Tumors In Brief This Week: Genprex, Strata Oncology, Bristol Myers Squibb, Turning Point Therapeutics Innovative Cellular Therapies Begins Trial of Autologous CAR T-Cell Therapy in Colorectal Cancer Personalis Adds Newly Issued Patent to Foresight Diagnostics Infringement Suit Sanofi Ends Development of Breast Cancer Drug Amcenestrant Tessa Therapeutics Starts Trial of CAR T-Cell Therapy, BMS's Opdivo in Classical Hodgkin Lymphoma